Elpida Therapeutics Announces Two Programs to be Advanced in Partnership with Bespoke Gene Therapy Consortium
Two of Elpida's pipeline programs for ultra-rare diseases, SPG50 and CMT4J, will get a significant boost having been included in the BGTC program portfolio. LOS ANGELES, CA, USA, May 17, 2023 /EINPresswire.com/ -- After recently announcing the …